関連する実験動画
Updated: Jun 20, 2025
04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
347
肥満 の ため の 薬: レビュー
Kimberly A Gudzune1,2, Robert F Kushner3,4
1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
JAMA
|July 22, 2024
まとめ
抗肥満薬 (AOM) は,肥満患者の体重減少と健康改善のための効果的な治療法です. 異なるAOMは,体重減少の異なる程度を提供し,異なる副作用のプロファイルを持っています.
科学分野:
- 薬理学と内分泌学
- 代謝 疾患
- クリニカル・セラピー
背景:
- 肥満 は 世界 的 な 健康 問題 で,何百万人もの 人々 に 影響 を 及ぼし,第 2 型 糖尿病,高血圧,脂質 失調 の 危険 を 増加 さ せ て い ます.
- 抗肥満薬 (AOM) は食欲と代謝に関連する生物学的プロセスをターゲットにすることで肥満の管理に不可欠です.
- AOMは,体重減少を促進し,心臓代謝の健康を改善するためのライフスタイル介入の補助剤として推奨されます.
研究 の 目的:
- 様々な抗肥満薬の効能と副作用を 検討する.
- ランダム化臨床試験のメタ解析に基づいて,異なるAOMの相対的な効力を比較する.
- ライフスタイルの変更と併用してAOMの使用に関する臨床実務を伝える.
主な方法:
- AOMとプラセボを比較したランダム化臨床試験 (RCT) の体系的レビューとメタ解析.
- 作用メカニズムに基づくAOMの分類:消化管の吸収変化,中央食欲調節,栄養素刺激ホルモン模倣.
- 各薬剤クラスで報告された減量率と一般的な副作用の分析
主要な成果:
- オルリスタット,フェンテルミン・トピラマート,ナルトレクソン・ブプロピオン,リラグルチド,セマグルチド,ティルゼパチドは,プラセボと比較して著しい体重減少を示した.
- セマグルチド (11. 4%) とティルゼパチド (12. 4%) がメタ解析で最も高い割合を示した.
- オルリスタットによる胃腸疾患,中央神経系への影響,または他の薬剤による胃腸疾患など,薬剤の種類によって副作用が異なっていた.
結論:
- 抗肥満薬は 肥満やそれに伴う疾患の管理に役立つ ツールです
- AOMの選択は,有効性,作用メカニズム,患者特有の副作用プロフィールを考慮する必要があります.
- AOMとライフスタイルの介入を統合することで 肥満の効果的な管理と 患者の改善のための包括的な戦略が提供されます
関連する概念動画
01:23Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
186
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
186
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
348
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
348
01:24Obesity
422
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
422
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
168
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
168
01:28Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41